Skip to main content
. 2019 Nov 19;2019(11):CD012187. doi: 10.1002/14651858.CD012187.pub2

Rehmani 2013.

Methods Allocation: randomized
Controlled: active comparator
Blinding: double‐blind
Arm: 2‐arm, parallel‐group design
Centre: single centre
Study duration: not reported
Participants Inclusion criteria: participants presenting to emergency department with acute painful crisis of SCD
Exclusion criteria: not reported
Baseline characteristics
N: 106 participants; 106 VOC episodes
Gender: not reported in abstract
Age: not reported
Number randomized: 54 intervention; 52 control
Number completed: not reported
Setting and location: King Abdulaziz Hospital, Al Ahsa, Saudi Arabia
Interventions Treatment group (54 participants; 54 VOC episodes):
  • single IV morphine 0.1 mg/kg


Control group (52 participants; 52 VOC episodes):
  • single IV paracetamol 1 g


Duration of treatment: duration of painful crisis
Follow‐up period: not reported
Cointerventions/additional analgesia: rescue analgesics
Outcomes Primary outcomes
  • Pain intensity (VAS 100 mm)

  • Pain intensity (VRS 1–4)

  • Change in pain intensity after 30 minutes


Secondary outcomes
  • Rescue analgesia (morphine)

  • Adverse effects

Notes Sources of funding: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "106 patients were randomised to treatment, morphine or paracetamol."
Comment: no clear method of randomization.
Allocation concealment (selection bias) Unclear risk Comment: insufficient information.
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Comment: insufficient information.
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Comment: insufficient information.
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Comment: insufficient information.
Selective reporting (reporting bias) High risk Comment: not all outcomes listed in methods were reported in the results, e.g. VRS; however, unclear due to abstract only.
Size Unclear risk Comment: total participants 106, 50–199 participants per treatment arm.
Other bias Low risk Comment: no other possible sources of bias.